Sharko Specification
Description : Each capsule contains 300 mg of extract from shark cartilage
|
Active Constituent Analysis |
SLH Product’s Specification/ |
Method |
|
Protein |
min. 80 mg |
Lowry |
|
D-Glucuronic acid |
min. 60 mg |
Carbazole |
|
Polysaccharide |
min. 20 mg |
Phenol Sulfuric Acid |
|
Heavy Metal |
|
|
|
Hg |
≤ 0.5 ppm |
AAS |
|
Cd |
≤ 0.3 ppm |
|
|
Pb |
≤ 10 ppm |
|
|
As |
≤ 5 ppm |
|
|
Typical Microbiological |
|
|
|
Total bacterial count |
< 30 cfu/g |
USP Method 61 |
|
Total yeast and mould count |
< 30 cfu/g |
|
|
Salmonella Sp. |
Negative |
Indonesian Pharmacopeia 4th Ed. 1995 |
|
Escherichia coli |
Negative |
|
|
Staphylococcus aureus |
Negative |
|
|
Pseudomonas aeruginosa |
Negative |
|
|
Shigella Sp. |
Negative |
Culture & Identification |
|
Physical Properties |
|
|
|
Appearance |
Powder |
Organoleptic Test |
|
Color |
White |
|
|
Odor |
Fish like |
|
|
Taste |
Tasteless |
|
|
Moisture Content |
≤ 10 % |
Indonesian Pharmacopeia 4th Ed. 1995 |
|
|
|
|
|
Packaging |
1 bottle @ 30 capsules |
|
|
Storage |
Keep in dry and cool place, avoid direct sun contact |
|
Document Number : SLH/SPESI/QC/04/004
The information contained herein is believed to be true and reliable.
Download PDF